m & m precision LLC

7341 tonawanda creek road
lockport, new york 14094

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 10, 2014

NYS DOS ID#
4590055

County
NIAGARA

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - M & M PRECISION LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • In a Precision Step, Bayer Writes Loxo $400M Check for Two Cancer Drugs
    By Ben Fidler - Tuesday Nov 14, 2017

    The latest evidence of the progress of targeted cancer drugs came this morning in the form of a $400 million check. That’s what Bayer will pay, up front, to Loxo Oncology, a company that has the chance to be the second, following Merck, to win approval of a drug for tumors with a specific genetic […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Strata Oncology, UCSF Partner to Offer $25M in Free Tumor Sequencing
    By Sarah Schmid Stevenson - Thursday Oct 5, 2017

    Ann Arbor, MI-based Strata Oncology this week announced a new partnership with the University of California, San Francisco, to provide $25 million in free tumor sequencing nationwide for men with metastatic prostate cancer. Called StratifyProstate, the initiative aims to dramatically increase enrollment in relevant precision medicine trials, says Strata CEO Dan Rhodes. Despite the significant promise […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart Bombs”
    By Frank Vinluan - Tuesday Nov 14, 2017

    A growing number of companies are using CRISPR technology to try and develop more precise treatments for a wide range of diseases, and Locus Biosciences is joining the mix, embracing the platform to tackle drug-resistant bacteria. Now the startup has $19 million to test its “precision antimicrobial” tech in humans. ARTIS Ventures, a San Francisco-based […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Analogue’s Super Nt comes with two SNES games, including a ‘Director’s Cut’
    By Darrell Etherington - Monday Oct 23, 2017

     The SNES Classic from Nintendo is pretty great, and it ships with the previously unreleased Star Fox 2 in the box. But Analogue’s amazing Super Nt – a precision engineered reference quality Super Nintendo console that can play the original cartridges – might just do one better.For its release, the creators are including a new, previously unreleased version of a game, too… Read More

    Source: TechCrunch
  • IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
    By Ben Fidler - Thursday Aug 3, 2017

    Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]

    Source: Xconomy VC, Deals, & Startups Feed
  • As Silicon Valley Gets ‘Crazy,’ Midwest Beckons Tech Investors
    By STEVE LOHR - Sunday Nov 19, 2017

    Funding and start-ups are concentrated on the coasts, especially in California. But there are signs of an entrepreneurial awakening in the heartland, where talent is rich but prices aren’t.

    Source: NYT > Home Page